Demant A/S
CSE:DEMANT
Demant A/S
CSE:DEMANT
Price:
195.6
DKK
0.88%
Market Closed
Market Cap:
kr41.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Demant A/S
CSE:DEMANT
|
DK |
|
Finsbury Food Group PLC
LSE:FIF
|
UK |
|
New Zealand King Salmon Co Ltd
NZX:NZK
|
NZ |
|
Hudson Technologies Inc
NASDAQ:HDSN
|
US |
|
S
|
Saxlund Group AB
STO:SAXG
|
SE |
|
B
|
Benares Hotels Ltd
BSE:509438
|
IN |
|
Midea Real Estate Holding Ltd
HKEX:3990
|
CN |
|
Xamble Group Ltd
ASX:XGL
|
MY |
|
F
|
FuJian YanJing HuiQuan Brewery Co Ltd
SSE:600573
|
CN |
|
Solar A/S
F:ZVR
|
DK |
|
China Nonferrous Mining Corp Ltd
HKEX:1258
|
CN |
|
Andhra Paper Ltd
NSE:ANDHRAPAP
|
IN |
|
Zorlu Enerji Elektrik Uretim AS
IST:ZOREN.E
|
TR |
|
UK Oil & Gas PLC
LSE:UKOG
|
UK |
|
X
|
Ximei Resources Holding Ltd
HKEX:9936
|
CN |
|
Learning Technologies Group PLC
LSE:LTG
|
UK |
|
Mercia Asset Management PLC
LSE:MERC
|
UK |
Multiples-Based Value
The
Multiples-Based Value for
Demant A/S (DEMANT)
under the Base Case is
hidden
DKK.
Compared with the current market price of 195.6 DKK, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DEMANT Multiples-Based Value
LOCKED
Multiples Across Competitors
DEMANT Competitors Multiples
Demant A/S Competitors
Demant A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Demant A/S
CSE:DEMANT
|
41.3B DKK | 1.8 | 27 | 10.8 | 15 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.6B USD | 4 | 27.4 | 15.7 | 21.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.5B USD | 15.9 | 56.2 | 42.5 | 52.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.8B USD | 5 | 39.1 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.2B USD | 3.1 | 24.1 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
93.2B USD | 4.6 | 32.1 | 19.1 | 25.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD | 7.8 | 43.9 | 24.1 | 26.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 1.7 | 19.2 | 10.8 | 15.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.4B USD | 10.6 | 42.9 | 30.4 | 33.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44B USD | 2 | 25 | 9.9 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.6B USD | 6 | 22 | 15.4 | 17.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
